Danaher Corporation vs Kraft Heinz Co — how do they compare? Danaher Corporation trades at $218.2 (market cap $152.87B), while Kraft Heinz Co trades at $22.37 (market cap $26.66B). The key difference: Danaher Corporation is far larger — about 5.7× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (7.12%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Kraft Heinz Co for 129 Days on average.
| DHR | KHC | |
|---|---|---|
Market Cap | $152.87B | $26.66B |
Volume | 5,228,698 | 31,300,109 |
Sector | Health | Consumer Staples |
52-Week High | $242.05 | $27.62 |
52-Week Low | $161.91 | $21.21 |
Typical Hold Time | 69 Days | 129 Days |
Enterprise Value | $175.08B | $42.98B |
Dividend Yield | 0.74% | 7.12% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Kraft Heinz (KHC) trades at $21.98, down 0.23% on the day, with a bearish technical signal and mixed fundamentals. The company reported a net loss of $5.85 billion in 2025 due to a significant impairment charge, though it has beaten EPS estimates for three consecutive quarters. Positive operating cash flow of $4.46 billion and a dividend yield near 7.3% provide some support, but high debt and declining revenue pose challenges.
The outlook remains cautious with a consensus price target of $23.78 suggesting modest upside. Risks include persistent volume declines, high leverage, and competitive pressures. The stock's deep value metrics (P/E of 13.04, P/B of 0.74) may attract contrarian investors, but sustained profitability improvement is needed for a durable rebound.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →